StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.00−0.08 (-0.88%)

Close on Nov 18, 2026Market cap $40.97MP/E –Yield –

Harvard Bioscience operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Harvard Bioscience's operating cash flow for the twelve months ending Jun 30, 2026 was $651.00K, down 90.2% year over year. For fiscal 2025 it was $6.73M, up 367.3% from the year before. Over ten years it grew 25.3% a year on average. The highest annual figure on record is $16.51M in fiscal 2009.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.73M+367.3%
FY2024Dec 31, 2024$1.44M-89.7%
FY2023Dec 31, 2023$14.03M+1117.7%
FY2022Dec 31, 2022$1.15M-8.7%
FY2021Dec 31, 2021$1.26M-86.5%
FY2020Dec 31, 2020$9.33M+16.0%
FY2019Dec 31, 2019$8.05M+179.0%
FY2018Dec 31, 2018$2.88M+172.8%
FY2017Dec 31, 2017$1.06M-80.4%
FY2016Dec 31, 2016$5.38M+663.5%
FY2015Dec 31, 2015$705.00K-83.8%
FY2014Dec 31, 2014$4.35M+7.2%
FY2013Dec 31, 2013$4.06M-49.6%
FY2012Dec 31, 2012$8.06M+21.3%
FY2011Dec 31, 2011$6.65M-45.9%
FY2010Dec 31, 2010$12.29M-25.5%
FY2009Dec 31, 2009$16.51M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$325.00K-88.2%
Q1 FY2026Mar 31, 2026-$662.00K-122.2%
Q4 FY2025Dec 31, 2025-$96.00K-105.6%
Q3 FY2025Sep 30, 2025$1.08M–
Q2 FY2025Jun 30, 2025$2.76M–
Q1 FY2025Mar 31, 2025$2.99M+112.8%
Q4 FY2024Dec 31, 2024$1.73M-59.9%
Q3 FY2024Sep 30, 2024-$842.00K-119.3%
Q2 FY2024Jun 30, 2024-$846.00K-123.8%
Q1 FY2024Mar 31, 2024$1.40M-22.6%
Q4 FY2023Dec 31, 2023$4.30M+60.6%
Q3 FY2023Sep 30, 2023$4.36M+572.0%
Q2 FY2023Jun 30, 2023$3.55M–
Q1 FY2023Mar 31, 2023$1.81M–
Q4 FY2022Dec 31, 2022$2.68M+2189.7%
Q3 FY2022Sep 30, 2022$649.00K–
Q2 FY2022Jun 30, 2022-$190.00K-124.7%
Q1 FY2022Mar 31, 2022-$1.99M-291.5%
Q4 FY2021Dec 31, 2021$117.00K-95.3%
Q3 FY2021Sep 30, 2021-$660.00K-141.3%
Q2 FY2021Jun 30, 2021$768.00K-67.6%
Q1 FY2021Mar 31, 2021$1.04M-63.9%
Q4 FY2020Dec 31, 2020$2.49M+12.2%
Q3 FY2020Sep 30, 2020$1.60M-49.4%
Q2 FY2020Jun 30, 2020$2.37M+261.2%
Q1 FY2020Mar 31, 2020$2.87M+42.8%
Q4 FY2019Dec 31, 2019$2.22M-14.4%
Q3 FY2019Sep 30, 2019$3.16M–
Q2 FY2019Jun 30, 2019$657.00K-48.6%
Q1 FY2019Mar 31, 2019$2.01M+348.7%
Q4 FY2018Dec 31, 2018$2.59M–
Q3 FY2018Sep 30, 2018-$1.43M-167.3%
Q2 FY2018Jun 30, 2018$1.28M+168.8%
Q1 FY2018Mar 31, 2018$448.00K–
Q4 FY2017Dec 31, 2017-$939.00K-154.4%
Q3 FY2017Sep 30, 2017$2.13M-38.1%
Q2 FY2017Jun 30, 2017$475.00K–
Q1 FY2017Mar 31, 2017-$610.00K–
Q4 FY2016Dec 31, 2016$1.73M–
Q3 FY2016Sep 30, 2016$3.44M–

More Harvard Bioscience figures

See a number that looks wrong?